arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

MEDICINOVA INC

MNOV
$1.34 0.00 (0.00%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
26 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
33
Health
Poor
Bearish
auto_awesome

Analytical Summary

MEDICINOVA INC faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $65.7M
Dividend Yield
Revenue Growth
Op. Margin None
ROIC -32.0%
FCF / Share $-0.20
Trailing P/E
Price / Book 1.6x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

26-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$409.66K
↓ -59.0%
Net Income Profit after all expenses
$-12.00M
↓ -8.6%
FCF / Share Free cash flow per share
$-0.20
↑ +7.8%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
24
Cash Quality
55

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 26 years · 77 quarters